{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T07:07:54Z","timestamp":1770966474504,"version":"3.50.1"},"reference-count":0,"publisher":"Portico","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1358\/dnp.2010.23.8.1507295","type":"journal-article","created":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T11:10:17Z","timestamp":1549883417000},"page":"475","source":"Crossref","is-referenced-by-count":12,"title":["Therapeutics that directly increase SMN expression to treat spinal\n                        muscular atrophy"],"prefix":"10.3730","volume":"23","author":[{"family":"Shababi, M.","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Mattis, V.B.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Lorson, C.L.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1320","published-online":{"date-parts":[[2010]]},"container-title":["Drug News & Perspectives"],"original-title":[],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T17:31:41Z","timestamp":1685467901000},"score":1,"resource":{"primary":{"URL":"http:\/\/access.portico.org\/stable?au=pjbf7k9v571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"references-count":0,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1358\/dnp.2010.23.8.1507295","relation":{},"ISSN":["2013-0139"],"issn-type":[{"value":"2013-0139","type":"print"}],"subject":[],"published":{"date-parts":[[2010]]}}}